| Kindest Care Healthcare Llc | |
| 8400 Bustleton Avenue, Suite 2, Philadelphia, Pennsylvania 19152 | |
| (215) 639-4646 | |
| Name | Kindest Care Healthcare Llc |
|---|---|
| Location | 8400 Bustleton Avenue, Suite 2, Philadelphia, Pennsylvania |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Home Health Aide |
| Medicare ID | 398104 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 18974, 19027, 19111, 19116, 19119, 19120, 19121, 19122, 19128, 19132, 19133, 19138, 19139, 19140, 19144, 19153 |
| NPI Number | 1356580393 |
| Organization Name | KINDEST CARE HEALTHCARE LLC |
| Address | 725 Wicker Ave, Suite 202, Bensalem, PA 19020 |
| Phone Number | 215-639-4646 |
News Archive
For the seventh consecutive year, the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety (OTS) that will help keep our roadways and senior drivers safe through professional training.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
Cardiovascular disease is one of the biggest contributors to the global burden of disease, and by 2020 will be the number one contributor according to figures from the World Health Organisation. In response, the International Centre for Circulatory Health (ICCH) has been set up by Imperial College London and St Mary's NHS Trust as an international research centre to develop new treatments and preventative strategies for cardiovascular disease around the world.
› Verified 6 days ago
| Quality Rating: |
News Archive
For the seventh consecutive year, the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety (OTS) that will help keep our roadways and senior drivers safe through professional training.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
Cardiovascular disease is one of the biggest contributors to the global burden of disease, and by 2020 will be the number one contributor according to figures from the World Health Organisation. In response, the International Centre for Circulatory Health (ICCH) has been set up by Imperial College London and St Mary's NHS Trust as an international research centre to develop new treatments and preventative strategies for cardiovascular disease around the world.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 94.9 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 89.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 94.3 | 99.6 |
| How often the home health team checked patients for depression | 73.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 71 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 67.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | - | 96.4 |
News Archive
For the seventh consecutive year, the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety (OTS) that will help keep our roadways and senior drivers safe through professional training.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
Cardiovascular disease is one of the biggest contributors to the global burden of disease, and by 2020 will be the number one contributor according to figures from the World Health Organisation. In response, the International Centre for Circulatory Health (ICCH) has been set up by Imperial College London and St Mary's NHS Trust as an international research centre to develop new treatments and preventative strategies for cardiovascular disease around the world.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 39.6 | 79.6 |
| How often patients got better at getting in and out of bed | 46.5 | 81.1 |
| How often patients got better at bathing | 31.1 | 82.3 |
| How often patients’ breathing improved | 25.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 47.7 | 75 |
| How often home health patients had to be admitted to the hospital | - | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | - | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 74.4 | 94 |
News Archive
For the seventh consecutive year, the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety (OTS) that will help keep our roadways and senior drivers safe through professional training.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
Cardiovascular disease is one of the biggest contributors to the global burden of disease, and by 2020 will be the number one contributor according to figures from the World Health Organisation. In response, the International Centre for Circulatory Health (ICCH) has been set up by Imperial College London and St Mary's NHS Trust as an international research centre to develop new treatments and preventative strategies for cardiovascular disease around the world.
› Verified 6 days ago
News Archive
For the seventh consecutive year, the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety (OTS) that will help keep our roadways and senior drivers safe through professional training.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.
Cardiovascular disease is one of the biggest contributors to the global burden of disease, and by 2020 will be the number one contributor according to figures from the World Health Organisation. In response, the International Centre for Circulatory Health (ICCH) has been set up by Imperial College London and St Mary's NHS Trust as an international research centre to develop new treatments and preventative strategies for cardiovascular disease around the world.
› Verified 6 days ago
Vna Of Greater Philadelphia Location: Falls Center, 3300 Henry Avenue, Suite 500, Philadelphia, Pennsylvania 19129 Ratings: Phone: (215) 473-0772 | |
Holy Redeemer Home Care-pa Location: 12265 Townsend Rd, Philadelphia, Pennsylvania 19154 Ratings: Phone: (215) 671-9200 | |
Homemaker Service Of The Metropolitan Area, Inc. Location: 444 North Third Street Ste 202, Philadelphia, Pennsylvania 19123 Ratings: NA Phone: (215) 592-0008 | |
Bayada Home Health Care, Inc. Location: 7600 Central Avenue, 3rd Floor, Founders Building, Philadelphia, Pennsylvania 19111 Ratings: Phone: (215) 728-4200 | |
Ken-care Home Health Agency Location: 6952 Germantown Avenue, 2nd Fl, Philadelphia, Pennsylvania 19119 Ratings: NA Phone: (215) 713-3880 | |